# Stereotaxis, Inc.: filings

STXS · NYSE · CIK 1289340 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/stxs.md) · [Financials](/companies/stxs/financials.md) · [Filings](/companies/stxs/filings.md) · [Insiders](/companies/stxs/insiders.md)

## Reports and events: 340 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 487, 8-K 213, 424B3 83, 10-Q 53, SC 13G/A 27, CORRESP 24, EFFECT 23, 3 22, DEF 14A 19, 10-K 18, 424B5 17, UPLOAD 17, DEFA14A 15, SD 13, SC 13G 12, POS AM 11, S-3 11, S-8 11, 4/A 10, S-1/A 9, 8-K/A 8, 10-K/A 5, D 5, S-1 5, PRE 14A 4, SC 13D 4, SC 13D/A 4, 25-NSE 3, 8-A12B 3, SC TO-I/A 3, 10-Q/A 2, 3/A 2, 424B2 2, CERTNAS 2, DEFR14A 2, S-3/A 2, SCHEDULE 13G 2, 5 1, CERT 1, CT ORDER 1, S-8 POS 1, SCHEDULE 13G/A 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-12 | 16:13 ET | [10-Q](/filings/0001493152-26-037357.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037357 |
| 2026-08-11 | 16:05 ET | [8-K](/filings/0001493152-26-037113.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037113 |
| 2026-07-16 | 17:37 ET | [8-K](/filings/0001493152-26-033405.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-033405 |
| 2026-07-09 | 08:13 ET | [8-K](/filings/0001493152-26-032598.md) | 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-032598 |
| 2026-05-15 | 15:31 ET | [8-K](/filings/0001493152-26-023654.md) | 5.07 Shareholder vote results | 0001493152-26-023654 |
| 2026-05-13 | 15:42 ET | [10-Q](/filings/0001493152-26-022697.md) | Quarterly report, period 2026-03-31 | 0001493152-26-022697 |
| 2026-05-12 | 16:10 ET | [8-K](/filings/0001493152-26-022488.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-022488 |
| 2026-04-15 | 07:15 ET | [8-K](/filings/0001493152-26-016685.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-016685 |
| 2026-04-03 | 17:00 ET | [10-K/A](/filings/0001493152-26-015172.md) | Annual report, amended, period 2025-12-31 | 0001493152-26-015172 |
| 2026-04-03 | 06:04 ET | [DEF 14A](/filings/0001493152-26-015027.md) | Proxy statement, period 2026-04-03 | 0001493152-26-015027 |
| 2026-03-12 | 16:52 ET | [10-K](/filings/0001493152-26-009881.md) | Annual report, period 2025-12-31 | 0001493152-26-009881 |
| 2026-03-09 | 16:05 ET | [8-K](/filings/0001493152-26-009366.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-009366 |
| 2025-11-12 | 15:39 ET | [10-Q](/filings/0001493152-25-021881.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021881 |
| 2025-11-12 | 09:00 ET | [8-K](/filings/0001493152-25-021772.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-021772 |
| 2025-08-29 | 17:00 ET | [8-K](/filings/0001641172-25-026031.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-026031 |
| 2025-08-13 | 15:00 ET | [10-Q](/filings/0001641172-25-023417.md) | Quarterly report, period 2025-06-30 | 0001641172-25-023417 |
| 2025-08-07 | 16:03 ET | [8-K](/filings/0001641172-25-022580.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-022580 |
| 2025-07-17 | 08:56 ET | [8-K](/filings/0001641172-25-019990.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-019990 |
| 2025-07-17 | 08:31 ET | [8-K](/filings/0001641172-25-019985.md) | 2.02 Results of operations; 8.01 Other events | 0001641172-25-019985 |
| 2025-05-19 | 12:13 ET | [8-K](/filings/0001641172-25-011415.md) | 5.07 Shareholder vote results | 0001641172-25-011415 |
| 2025-05-13 | 16:00 ET | [10-Q](/filings/0001641172-25-009933.md) | Quarterly report, period 2025-03-31 | 0001641172-25-009933 |
| 2025-05-12 | 16:05 ET | [8-K](/filings/0001641172-25-009667.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009667 |
| 2025-04-04 | 16:00 ET | [DEF 14A](/filings/0001641172-25-002746.md) | Proxy statement, period 2025-04-04 | 0001641172-25-002746 |
| 2025-03-14 | 16:02 ET | [10-K](/filings/0001493152-25-010352.md) | Annual report, period 2024-12-31 | 0001493152-25-010352 |
| 2025-03-03 | 07:35 ET | [8-K](/filings/0001493152-25-008810.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-008810 |
| 2024-11-14 | 16:49 ET | [10-Q](/filings/0001493152-24-045994.md) | Quarterly report, period 2024-09-30 | 0001493152-24-045994 |
| 2024-11-12 | 09:00 ET | [8-K](/filings/0001493152-24-044573.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-044573 |
| 2024-08-14 | 13:40 ET | [10-Q](/filings/0001493152-24-032047.md) | Quarterly report, period 2024-06-30 | 0001493152-24-032047 |
| 2024-08-12 | 16:07 ET | [8-K](/filings/0001493152-24-031266.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-031266 |
| 2024-08-02 | 09:05 ET | [8-K](/filings/0001493152-24-029986.md) | 3.02 Unregistered sale of equity; 8.01 Other events | 0001493152-24-029986 |
| 2024-07-18 | 17:06 ET | [8-K](/filings/0001493152-24-028364.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-028364 |
| 2024-05-16 | 17:00 ET | [8-K](/filings/0001493152-24-020281.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.07 Shareholder vote results | 0001493152-24-020281 |
| 2024-05-15 | 10:35 ET | [10-Q](/filings/0001493152-24-019608.md) | Quarterly report, period 2024-03-31 | 0001493152-24-019608 |
| 2024-05-13 | 16:10 ET | [8-K](/filings/0001493152-24-018881.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-018881 |
| 2024-04-04 | 15:50 ET | [DEF 14A](/filings/0001493152-24-013167.md) | Proxy statement, period 2023-12-31 | 0001493152-24-013167 |
| 2024-03-08 | 15:21 ET | [10-K](/filings/0001493152-24-009371.md) | Annual report, period 2023-12-31 | 0001493152-24-009371 |
| 2024-03-04 | 16:06 ET | [8-K](/filings/0001493152-24-008704.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-008704 |
| 2023-11-13 | 09:05 ET | [10-Q](/filings/0001493152-23-040354.md) | Quarterly report, period 2023-09-30 | 0001493152-23-040354 |
| 2023-11-09 | 09:05 ET | [8-K](/filings/0001493152-23-040008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-040008 |
| 2023-08-11 | 09:05 ET | [10-Q](/filings/0001493152-23-027738.md) | Quarterly report, period 2023-06-30 | 0001493152-23-027738 |
| 2023-08-10 | 09:05 ET | [8-K](/filings/0001493152-23-027465.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-027465 |
| 2023-06-15 | 16:15 ET | [8-K](/filings/0001493152-23-021433.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-021433 |
| 2023-05-19 | 17:00 ET | [8-K](/filings/0001493152-23-018391.md) | 5.07 Shareholder vote results | 0001493152-23-018391 |
| 2023-05-12 | 17:01 ET | [10-Q](/filings/0001493152-23-016720.md) | Quarterly report, period 2023-03-31 | 0001493152-23-016720 |
| 2023-05-09 | 09:05 ET | [8-K](/filings/0001493152-23-015876.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-015876 |
| 2023-04-05 | 16:05 ET | [DEF 14A](/filings/0001493152-23-011022.md) | Proxy statement, period 2023-04-05 | 0001493152-23-011022 |
| 2023-03-09 | 15:38 ET | [10-K](/filings/0001493152-23-007106.md) | Annual report, period 2022-12-31 | 0001493152-23-007106 |
| 2023-03-03 | 09:05 ET | [8-K](/filings/0001493152-23-006634.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-006634 |
| 2022-11-14 | 11:03 ET | [10-Q](/filings/0001493152-22-031744.md) | Quarterly report, period 2022-09-30 | 0001493152-22-031744 |
| 2022-11-10 | 09:00 ET | [8-K](/filings/0001493152-22-031248.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-031248 |

Page 1 of 7. [Older](/companies/stxs/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.